Natural Alternatives International Hits 52-Week Low at $2.15

Natural Alternatives International, Inc., a microcap company in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 2.15 as of July 20, 2026. This marks a significant decline, with the stock's performance over the past year reflecting a decrease of 66.92%, starkly contrasting with the S&P 500's gain of 18.21% during the same period. The company's market capitalization stands at USD 26 million, indicating its microcap status. Financial metrics reveal a challenging landscape, with a return on equity of -15.73% and a price-to-book ratio of 0.39, suggesting undervaluation relative to its assets. The company has not paid dividends, and its debt-to-equity ratio is relatively low at 0.20. Natural Alternatives International has faced substantial operational difficulties, evidenced by a significant decline in operating profit, which has decreased at an annual rate of -199.84% over the last five years. The latest financial results indicate a net profit of USD -4.21 million, a drop of 59.72%. This consistent underperformance against market benchmarks raises concerns about the company's financial health and operational efficiency.